🇺🇸 FDA
Patent

US 8865210

Stable dosage formulations of imidazolylalkyl-pyridines

granted A61KA61K31/70A61K9/4858

Quick answer

US patent 8865210 (Stable dosage formulations of imidazolylalkyl-pyridines) held by VANDA PHARMACEUTICALS INC. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/70, A61K9/4858, A61K9/4866